PH17738A - Preparation of homogeneous human fibroblast interferon - Google Patents

Preparation of homogeneous human fibroblast interferon

Info

Publication number
PH17738A
PH17738A PH24361A PH24361A PH17738A PH 17738 A PH17738 A PH 17738A PH 24361 A PH24361 A PH 24361A PH 24361 A PH24361 A PH 24361A PH 17738 A PH17738 A PH 17738A
Authority
PH
Philippines
Prior art keywords
preparation
human fibroblast
fibroblast interferon
homogeneous human
homogeneous
Prior art date
Application number
PH24361A
Other languages
English (en)
Inventor
Heinz-Jurgen Friesen
Sidney Pestka
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH17738A publication Critical patent/PH17738A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PH24361A 1979-07-31 1980-07-29 Preparation of homogeneous human fibroblast interferon PH17738A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6237179A 1979-07-31 1979-07-31
US13063580A 1980-03-14 1980-03-14

Publications (1)

Publication Number Publication Date
PH17738A true PH17738A (en) 1984-11-23

Family

ID=26742182

Family Applications (2)

Application Number Title Priority Date Filing Date
PH24361A PH17738A (en) 1979-07-31 1980-07-29 Preparation of homogeneous human fibroblast interferon
PH29729A PH18479A (en) 1979-07-31 1983-10-21 Homogeneous human fibrolast interferon

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH29729A PH18479A (en) 1979-07-31 1983-10-21 Homogeneous human fibrolast interferon

Country Status (33)

Country Link
US (1) US5015730A (da)
JP (1) JPH02138226A (da)
AR (1) AR229931A1 (da)
AT (1) AT372387B (da)
AU (1) AU536274B2 (da)
CA (1) CA1146468A (da)
CH (1) CH648331A5 (da)
DE (1) DE3028919A1 (da)
DK (1) DK159825C (da)
DO (1) DOP1980002948A (da)
ES (1) ES8200560A1 (da)
FI (1) FI70721C (da)
FR (1) FR2462167B1 (da)
GB (1) GB2055384B (da)
HK (1) HK40384A (da)
HU (1) HU185382B (da)
IE (1) IE50075B1 (da)
IL (1) IL60697A (da)
IT (1) IT1132269B (da)
KE (1) KE3364A (da)
LU (1) LU82673A1 (da)
MC (1) MC1337A1 (da)
MY (1) MY8500274A (da)
NL (1) NL8004361A (da)
NO (1) NO151158C (da)
NZ (1) NZ194495A (da)
PH (2) PH17738A (da)
PT (1) PT71625B (da)
RO (1) RO81474B (da)
SE (1) SE466290B (da)
YU (1) YU193480A (da)
ZA (1) ZA803943B (da)
ZW (1) ZW17980A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL62552A0 (en) 1980-04-03 1981-06-29 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human fibroblast interferon-like polypeptides
GR81946B (da) * 1980-09-25 1984-12-12 Genentech Inc
ZA83768B (en) * 1982-03-01 1983-10-26 Hoffmann La Roche Homogeneous human immune interferon and process therefor
US4966843A (en) * 1982-11-01 1990-10-30 Cetus Corporation Expression of interferon genes in Chinese hamster ovary cells
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4894330A (en) * 1986-12-23 1990-01-16 Cetus Corporation Purification of recombinant beta-interferon incorporating RP-HPLC
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US20030026779A1 (en) * 1999-10-15 2003-02-06 Liming Yu Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US20050002902A1 (en) * 1995-12-28 2005-01-06 Liming Yu Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
CN101282990B (zh) 2005-08-26 2013-04-03 阿雷斯贸易股份有限公司 糖基化干扰素-β的制备方法
JP5199112B2 (ja) 2005-12-09 2013-05-15 アレス トレーディング ソシエテ アノニム Ｆｓｈ又はｆｓｈ変異体を精製するための方法
AU2008314687A1 (en) * 2007-10-22 2009-04-30 Merck Serono S.A. Method for purifying Fc-fusion proteins
DE102009032179A1 (de) 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta

Also Published As

Publication number Publication date
AT372387B (de) 1983-09-26
JPH02138226A (ja) 1990-05-28
ZA803943B (en) 1981-06-24
ES493849A0 (es) 1981-11-16
DE3028919C2 (da) 1988-02-18
YU193480A (en) 1984-04-30
IL60697A0 (en) 1980-09-16
MC1337A1 (fr) 1981-04-21
AU6091480A (en) 1981-02-05
NZ194495A (en) 1984-07-31
DK328880A (da) 1981-02-01
NO151158C (no) 1985-02-20
RO81474B (ro) 1983-04-30
CH648331A5 (de) 1985-03-15
HK40384A (en) 1984-05-18
FI70721B (fi) 1986-06-26
GB2055384A (en) 1981-03-04
PT71625A (en) 1980-08-01
SE466290B (sv) 1992-01-27
DK159825C (da) 1991-04-29
HU185382B (en) 1985-01-28
DK159825B (da) 1990-12-10
IE801589L (en) 1981-01-31
ZW17980A1 (en) 1981-03-18
ES8200560A1 (es) 1981-11-16
IT8023801A0 (it) 1980-07-30
IE50075B1 (en) 1986-02-05
MY8500274A (en) 1985-12-31
GB2055384B (en) 1983-08-10
FR2462167B1 (fr) 1985-07-05
FI70721C (fi) 1986-10-06
US5015730A (en) 1991-05-14
AR229931A1 (es) 1984-01-31
CA1146468A (en) 1983-05-17
RO81474A (ro) 1983-04-29
NL8004361A (nl) 1981-02-03
PT71625B (en) 1981-12-17
NO151158B (no) 1984-11-12
SE8005498L (sv) 1981-02-01
AU536274B2 (en) 1984-05-03
LU82673A1 (fr) 1982-02-17
KE3364A (en) 1984-02-03
PH18479A (en) 1985-07-18
FI802400A (fi) 1981-02-01
IL60697A (en) 1984-04-30
DE3028919A1 (de) 1981-02-19
NO802297L (no) 1981-02-02
FR2462167A1 (fr) 1981-02-13
ATA395080A (de) 1983-02-15
DOP1980002948A (es) 1989-04-20
IT1132269B (it) 1986-07-02

Similar Documents

Publication Publication Date Title
GB2040292B (en) Type ii interferon and therapeutic and prophylactic compositions
ZA782355B (en) (pyrimidyloxy)phenoxy-alkanecarboxylic acids and their preparation and use
DE3262575D1 (en) Stabilised interferon formulations and their preparation
GB2098996B (en) Microbial production of human fibroblast interferon
DE3467772D1 (en) Analogs of human interleukin ii and their preparation
NZ187452A (en) N- substituted-aminocarbonylpropoxy-carbostyrils and their preparation
JPS5430277A (en) Oligooheteropolysucrides of heparinnlike activity*preparation thereof and composition based thereon
DE2962359D1 (en) Method of purification of human fibroblast interferon
PH17738A (en) Preparation of homogeneous human fibroblast interferon
JPS55124534A (en) Continuous preparation of microocapsules
GB2054596B (en) Preparation of citrovorum factor
ZW12380A1 (en) Novel 3-vinyl-cephalosporins and their preparation
GB8305506D0 (en) Homogeneous human immune interferon
JPS5598119A (en) Manufacture of interferon
GB2010806A (en) Pyrindines and their preparation formulations and use
ZA802578B (en) Preparation of aryl-monourethanes and aryl-polyurethanes
IL61039A0 (en) Preparation of 1-azolyl-1-phenoxy-alkan-2-ones and 1-azolyl-1-halo-alkan-2-ones used therefor
JPS5622794A (en) Human fibroblast interferon
IL56031A0 (en) Novel dichlorovinylcyclobutanones and their preparation
MW3881A1 (en) Microbial production of human fibroblast interferon
GB2121050B (en) Preparation of functional human urokinase proteins
JPS55164112A (en) Preparation of sheettlike ceramic
IE800645L (en) Preparation of interferon
IL72339A0 (en) Pgf1-derivatives and their preparation

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 12